How many institutions held SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in Q1 2021?

14 institutional investors reported SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share for Q1 2021. Use the holders table for investor-level position and value details.

SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)

Q: What does CUSIP P8696W104 represent in this 13F holders report?

CUSIP P8696W104 is the security identifier for SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share used to aggregate holder disclosures.

CUSIP: P8696W104

Q1 2021 13F Holders as of 31 Mar 2021

Security type / class: Equity / Common Shares, par value US$0.001 per share
Total 13F shares: 6,694,343
Total 13F value: $43,301,798
Share change: +127,573
SEC-reported price per share: $6.47
Number of holders: 14
Value change: +$795,406
Number of buys: 4
Number of sells: 2
Shares outstanding: 71,872,133

Security key

P8696W104

Report period

Q1 2021

Institutions

Top holders

SVA full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 SINOVAC BIOTECH LTD SEC filings SINOVAC BIOTECH LTD company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP P8696W104

Newer quarter: Q3 2025

Recent filing periods:

Q3 2026 Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

0/15

Latest evidence

31 Dec 2020

13F Highest disclosed value: $72,000,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $72M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Disclosed position value Top 5

ORBIMED ADVISORS LLC $72M

SAIF Advisors Ltd $69.75M

Vivo Capital, LLC $38.17M

Neumann Advisory Hong Kong Ltd $2.04M

RENAISSANCE TECHNOLOGIES LLC $1.54M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$72,000,000 2,839,500 shares	—	31 Dec 2020
SAIF Advisors Ltd	13F Company 13F	— denominator unverified	$69,752,000 10,780,820 shares	—	31 Dec 2020
Vivo Capital, LLC	13F Company 13F	— denominator unverified	$38,173,000 5,900,000 shares	—	31 Dec 2020
Neumann Advisory Hong Kong Ltd	13F Company 13F	— denominator unverified	$2,042,000 315,586 shares	—	31 Dec 2020
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$1,537,000 2,375,841 shares	—	31 Dec 2020
STATE STREET CORP	13F Company 13F	— denominator unverified	$1,041,000 160,875 shares	—	31 Dec 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

6,694,343

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q2 2026 Across Filers

Q2 2026 holders

Q1 2021 holders

Holder diff

Investor	Q2 2026 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q2 2026 value	Q1 2021 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend